Dr. Peter W. Mclaughlin, MD
- Part D claims, 2018
- 11
- Publications
- 170
- Clinical trials
- 3
- Industry payments
- $84,315
- State license
- 1
- Practice address
- 1515 Holcombe Blvd, Houston, TX 77030-4009
- Practice phone
- Call (713) 792-6161
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Mclaughlin's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Peter W. Mclaughlin is a medical oncologist in Houston, Texas
Dr. Mclaughlin practices in Houston, Texas.
Dr. Mclaughlin's NPI, 1316010929, was assigned on November 15, 2006. Dr. Mclaughlin graduated from Tufts University School Of Medicine in 1974. Dr. Mclaughlin holds Texas license F7533.
- NPI
- 1316010929NPI Registry (opens in a new tab)
- NPI enumeration date
- November 15, 2006
- NPI status
- Active
- Practice phone
- (713) 792-6161
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Medical school graduation
- 1974
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dr. Peter W. Mclaughlin's practice address is in Houston, Texas
Dr. Mclaughlin's practice address in the NPI Registry is 1515 Holcombe Blvd, Houston, TX 77030-4009. The practice phone is (713) 792-6161.
- NPI Registry address1515 Holcombe Blvd, Houston, TX 77030-4009Phone(713) 792-6161
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Peter W. Mclaughlin's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mclaughlin practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Mclaughlin's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Peter W. Mclaughlin is one of 484 medical oncologists in Texas
Medical oncology is Dr. Mclaughlin's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Mclaughlin is board certified in hematology by the American Board of Internal Medicine. Dr. Mclaughlin is licensed in Texas.
Specialties and state licenses
- Medical oncology, TexasPrimary
Medical oncologists near Dr. Mclaughlin
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Peter W. Mclaughlin wrote 11 Medicare Part D claims in 2018
In 2018, Dr. Mclaughlin wrote 11 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $81 in total drug cost.
Dr. Mclaughlin's most prescribed drugs by claims, 2018
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Peter W. Mclaughlin has 170 publications on record
Dmand AI links 170 papers to Dr. Mclaughlin, published from 2004 to 2020. 2015 was the busiest year, with 6. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Lymphoma, Non-Hodgkin and Rituximab. Dr. Mclaughlin has published most often in Leuk Lymphoma. Dr. Mclaughlin's most frequent co-authors are Fredrick B. Hagemeister, MD, Luis E. Fayad, MD and Felipe Samaniego, MD, MPH.
Dr. Mclaughlin's papers by year, 2008 to 2020
Topics Dr. Mclaughlin writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Lymphoma, Non-Hodgkin
- Rituximab
- Antibodies, Monoclonal, Murine-Derived
- Antibodies, Monoclonal
- Lymphoma, Follicular
- Cyclophosphamide
- Antineoplastic Agents
Dr. Mclaughlin's most frequent co-authors
- Fredrick B. Hagemeister, MD58 shared papers
- Luis E. Fayad, MD35 shared papers
- Felipe Samaniego, MD, MPH25 shared papers
Recent publications by Dr. Mclaughlin
See who Dr. Mclaughlin researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Mclaughlin works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Peter W. Mclaughlin has worked on 3 clinical trials
Dmand AI links Dr. Mclaughlin to 3 clinical trials, 2 of them phase 2 studies. Conditions studied include Lymphoma, Lymphoma, Non-Hodgkin and Rare Diseases.
Conditions in Dr. Mclaughlin's trials
- Lymphoma
- Lymphoma, Non-Hodgkin
- Rare Diseases
- Lymphatic Diseases
- Lymphoma, Follicular
Investigators on the most trials with Dr. Mclaughlin
- Nancy Lee Bartlett, MD1 shared trial
- Ralph V. Boccia, MD1 shared trial
- Januario E. Castro1 shared trial
Recent clinical trials with Dr. Mclaughlin
Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients (opens in a new tab)
Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Peter W. Mclaughlin received $84,315 in industry payments from 2016 to 2024
CMS Open Payments shows 20 general payments to Dr. Mclaughlin from 5 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 82% of the total. Celgene Corporation paid the most, $40,808.
General payments to Dr. Mclaughlin by program year, 2016 to 2024
General payments to Dr. Mclaughlin by kind, 2016 to 2024
- Consulting fees$68,92682%
- Honoraria$13,05015%
- Travel and lodging$1,7322%
- Food and beverage$4871%
- Education$1210%
Companies that paid Dr. Mclaughlin the most, 2016 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Peter W. Mclaughlin has 1 award and honors on record
Dmand AI lists 1 award for Dr. Mclaughlin, most recently Regional Top Doctor in 2014.
Awards and honors for Dr. Mclaughlin
- 2014
- Regional Top Doctor
Source: Dmand AI Professional Profile Data
Dr. Peter W. Mclaughlin graduated from Tufts University School Of Medicine
Dr. Mclaughlin graduated from Tufts University School Of Medicine in 1974.
- Medical school
- Board certified in hematology
- Board certified in internal medicine
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Sources for Dr. Peter W. Mclaughlin's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Peter W. Mclaughlin
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Peter W. Mclaughlin's NPI number?
Dr. Peter W. Mclaughlin's NPI number is 1316010929. It was assigned on November 15, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Peter W. Mclaughlin?
Dr. Peter W. Mclaughlin is a medical oncologist in Houston, Texas. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Peter W. Mclaughlin practice?
Dr. Mclaughlin practices at 1515 Holcombe Blvd, Houston, TX 77030-4009.
What is Dr. Peter W. Mclaughlin's office phone number?
The practice phone on file for Dr. Mclaughlin is (713) 792-6161.
What is Dr. Peter W. Mclaughlin's medical license number?
Dr. Mclaughlin holds Texas license F7533.
Is Dr. Peter W. Mclaughlin board certified?
Yes. Dr. Mclaughlin is board certified in hematology by the American Board of Internal Medicine.
Where did Dr. Peter W. Mclaughlin go to medical school?
Dr. Mclaughlin graduated from Tufts University School Of Medicine in 1974.
What drugs does Dr. Peter W. Mclaughlin prescribe most?
In 2018 Medicare Part D data, Dr. Mclaughlin's most prescribed drugs by claims were Tamsulosin HCl.
Has Dr. Peter W. Mclaughlin received payments from drug or device companies?
CMS Open Payments shows $84,315 in general payments to Dr. Mclaughlin from 5 companies from 2016 to 2024. The largest total came from Celgene Corporation.
How long has Dr. Peter W. Mclaughlin been practicing?
Dr. Mclaughlin graduated from medical school in 1974, 52 years ago.
Does Dr. Peter W. Mclaughlin do research?
Dmand AI links 170 publications to Dr. Mclaughlin, published from 2004 to 2020. Dr. Mclaughlin has worked on 3 clinical trials.
Who does Dr. Peter W. Mclaughlin publish with?
Dr. Mclaughlin's most frequent co-authors are Fredrick B. Hagemeister, MD (58 shared papers), Luis E. Fayad, MD (35 shared papers) and Felipe Samaniego, MD, MPH (25 shared papers).
Selling to medical oncology practices?
See medical oncologists in Texas by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card